Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy

scientific article published in August 1990

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00007890-199008000-00002
P932PMC publication ID2978534
P698PubMed publication ID1696405
P5875ResearchGate publication ID21460182

P50authorThomas E. StarzlQ1248240
John Julian FungQ61476062
P2093author name stringD G Kim
S Todo
N Murase
D V Cramer
P2860cites workFK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristicsQ28338447
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporineQ33993321
Orthotopic liver transplantation in dogs receiving FK-506.Q33993452
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.Q33993531
FK 506 for liver, kidney, and pancreas transplantationQ34252199
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.Q34275070
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.Q34942525
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.Q37175908
Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainageQ41056811
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOGQ41765997
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS.Q42219748
Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in ratsQ43900523
Studies of the effects of FK506 on renal allografting in the beagle dog.Q45126785
Observations of orthotopic liver transplantation in the pigQ54137294
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activationQ69002726
Heterotopic heart transplantation in the rat receiving FK-506Q69009057
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitroQ69010285
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivityQ69054997
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2Q69055001
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genesQ69079614
Renal transplantation in baboons under FK 506Q69092046
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the ratQ69135605
Improved technique of heart transplantation in ratsQ69867057
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)186-189
P577publication date1990-08-01
P1433published inTransplantationQ15730500
P1476titleSuppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy
P478volume50

Reverse relations

cites work (P2860)
Q34498286A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results
Q71672283A protocol with FK 506 for inducing unresponsiveness to murine islet allografts
Q41662679A short course of FK506 can induce limited donor-specific graft acceptance
Q73219472A successful induction of tolerance by perioperative intrathymic injection in rat "high-responder" heart transplantation
Q35253580Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction
Q34187736Adverse effects associated with the use of FK 506
Q34470498An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders
Q34241674Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance
Q34178622Cell migration, chimerism, and graft acceptance
Q71695988Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection
Q45892648Comparative studies of the effects of FK506 and cyclosporin A on passively transferred collagen-induced arthritis in rats
Q34197027Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls
Q34204368Current status of FK 506 in liver transplantation
Q33612327Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection
Q34237899Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression
Q73033656Effect of a single injection of high-dose FK506 on lung transplantation in rats
Q71627745Experimental rat pancreas transplant: surgical technique and immunological considerations
Q34207851FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats
Q36614950FK 506: an immunosuppressant for the 1990s?
Q40491507FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects
Q34207804FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats
Q73984402Immunosuppression in auxiliary partial liver transplantation with FK506 in rats
Q71627747Limited effectiveness of FK506 administration for ongoing rejection in heterotopic rat heart transplantation
Q34281142Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats
Q35605951Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat
Q41888677Orthotopic liver transplantation in the mouse
Q42719296Overview of FK506 in transplantation
Q71619744Peripheral blood and intrahepatic subsets of T lymphocyte activation and function in liver allograft rejection and drug-induced tolerance in rats
Q34286877Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506.
Q34275901Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors
Q67531765Renal transplantation for the nephrologist: new immunosuppressive drugs
Q40390963Tacrolimus, a new immunosuppressant--a review of the literature
Q40385566Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation
Q45060105The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents
Q36686159The immunosuppressive macrolides FK-506 and rapamycin
Q98222297Understanding, predicting and achieving liver transplant tolerance: from bench to bedside
Q34357964Xenobiotics, chimerism and the induction of tolerance following organ transplantation
Q53014428[Immunologic tolerance after experimental liver transplantation].